<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30145090</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>10</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>10</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1769-6658</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>22</Volume>                    <Issue>6-7</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique</Title>                <ISOAbbreviation>Cancer Radiother</ISOAbbreviation>            </Journal>            <ArticleTitle>[The major debate: Micrometastases and breast cancer - To be for nodal irradiation].</ArticleTitle>            <Pagination>                <MedlinePgn>478-480</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S1278-3218(18)30284-1</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.canrad.2018.07.129</ELocationID>            <Abstract>                <AbstractText>Standard of care in breast cancer management is well-defined. However, some gray zones still exist, in particular adjuvant radiotherapy indications in case of pN1mi breast cancer. Here we propose to define their prognosis, to underpin the benefit of adjuvant treatments in such patients' management and to define lymphedema risk, which is the most common late side effect of locoregional treatments.</AbstractText>                <CopyrightInformation>Copyright © 2018 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Bourgier</LastName>                    <ForeName>C</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Inserm U1194, institut de recherche en cancérologie de Montpellier (IRCM), université de Montpellier, Montpellier, France; Institut régional du cancer de Montpellier (ICM)-Val D'Aurelle, 208, avenue des Apothicaires, 34298 Montpellier, France; Faculté de médecine, Montpellier, France. Electronic address: celine.bourgier@montpellier.unicancer.fr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lemanski</LastName>                    <ForeName>C</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Institut régional du cancer de Montpellier (ICM)-Val D'Aurelle, 208, avenue des Apothicaires, 34298 Montpellier, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fenoglietto</LastName>                    <ForeName>P</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Institut régional du cancer de Montpellier (ICM)-Val D'Aurelle, 208, avenue des Apothicaires, 34298 Montpellier, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Azria</LastName>                    <ForeName>D</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Inserm U1194, institut de recherche en cancérologie de Montpellier (IRCM), université de Montpellier, Montpellier, France; Institut régional du cancer de Montpellier (ICM)-Val D'Aurelle, 208, avenue des Apothicaires, 34298 Montpellier, France; Faculté de médecine, Montpellier, France.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>fre</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <VernacularTitle>Le grand débat : cancers du sein pN1mi – pour l’irradiation des aires ganglionnaires.</VernacularTitle>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>23</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>France</Country>            <MedlineTA>Cancer Radiother</MedlineTA>            <NlmUniqueID>9711272</NlmUniqueID>            <ISSNLinking>1278-3218</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>                <QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName>                <QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D061206" MajorTopicYN="N">Neoplasm Micrometastasis</DescriptorName>                <QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Cancer du sein</Keyword>            <Keyword MajorTopicYN="N">Micrometastase</Keyword>            <Keyword MajorTopicYN="N">Micrométastase</Keyword>            <Keyword MajorTopicYN="N">Radiothérapie ganglionnaire</Keyword>            <Keyword MajorTopicYN="N">Regional nodal irradiation</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>06</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>06</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30145090</ArticleId>            <ArticleId IdType="pii">S1278-3218(18)30284-1</ArticleId>            <ArticleId IdType="doi">10.1016/j.canrad.2018.07.129</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>